DK1701940T3 - 2-(1H-indolylsulfanyl)-bensylaminderivater som SSRI - Google Patents
2-(1H-indolylsulfanyl)-bensylaminderivater som SSRIInfo
- Publication number
- DK1701940T3 DK1701940T3 DK04803045T DK04803045T DK1701940T3 DK 1701940 T3 DK1701940 T3 DK 1701940T3 DK 04803045 T DK04803045 T DK 04803045T DK 04803045 T DK04803045 T DK 04803045T DK 1701940 T3 DK1701940 T3 DK 1701940T3
- Authority
- DK
- Denmark
- Prior art keywords
- indolylsulfanyl
- ssris
- benzylamine derivatives
- derivatives
- benzylamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53259303P | 2003-12-23 | 2003-12-23 | |
DKPA200301923 | 2003-12-23 | ||
PCT/DK2004/000894 WO2005061455A1 (en) | 2003-12-23 | 2004-12-21 | 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1701940T3 true DK1701940T3 (da) | 2008-09-08 |
Family
ID=34712442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04803045T DK1701940T3 (da) | 2003-12-23 | 2004-12-21 | 2-(1H-indolylsulfanyl)-bensylaminderivater som SSRI |
Country Status (18)
Country | Link |
---|---|
US (4) | US7563908B2 (da) |
EP (1) | EP1701940B1 (da) |
JP (3) | JP4090491B2 (da) |
AT (1) | ATE396970T1 (da) |
AU (1) | AU2004303461B2 (da) |
BR (1) | BRPI0417858B1 (da) |
CY (2) | CY1108230T1 (da) |
DE (1) | DE602004014190D1 (da) |
DK (1) | DK1701940T3 (da) |
ES (1) | ES2303960T3 (da) |
HR (2) | HRP20080274T3 (da) |
IL (1) | IL176111A (da) |
MX (1) | MXPA06007172A (da) |
PL (1) | PL1701940T3 (da) |
PT (1) | PT1701940E (da) |
RS (1) | RS50589B (da) |
SI (1) | SI1701940T1 (da) |
WO (1) | WO2005061455A1 (da) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2303960T3 (es) * | 2003-12-23 | 2008-09-01 | H. Lundbeck A/S | Derivados de 2-(1h-indolilsulfanil)-bencilamina como isrs. |
AR052308A1 (es) * | 2004-07-16 | 2007-03-14 | Lundbeck & Co As H | Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto |
AR054394A1 (es) * | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de 2- (1h-indolilsulfanil)-aril amina |
AR054393A1 (es) | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos. |
US7629473B2 (en) | 2005-06-17 | 2009-12-08 | H. Lundbeck A/S | 2-(1H-indolylsulfanyl)-aryl amine derivatives |
US20090054510A1 (en) * | 2006-03-22 | 2009-02-26 | H. Lundbeck A/S | Method for identifying compounds for the treatment of depression |
TW200819426A (en) * | 2006-08-31 | 2008-05-01 | Lundbeck & Co As H | Novel indane compounds |
CA2664258A1 (en) * | 2006-09-28 | 2008-04-03 | H. Lundbeck A/S | [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
CN101563320B (zh) * | 2006-09-28 | 2012-05-30 | H.隆德贝克有限公司 | 用于治疗情感障碍的[2-(6-氟-1h-吲哚-3-基硫烷基)苄基]甲胺 |
JP2010540461A (ja) * | 2007-09-24 | 2010-12-24 | ハー・ルンドベック・アクチエゼルスカベット | セロトニン二重作用化合物に関する併用療法 |
TW200938189A (en) * | 2008-03-13 | 2009-09-16 | Lundbeck & Co As H | [2-(6-flouro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders |
JP2011528005A (ja) * | 2008-07-15 | 2011-11-10 | エフ.ホフマン−ラ ロシュ アーゲー | 置換インドリル及びインダゾリル誘導体及びそれらの使用 |
EP2606031B1 (en) * | 2010-08-20 | 2017-09-27 | Amira Pharmaceuticals, Inc. | Autotaxin inhibitors and uses thereof |
US9260416B2 (en) | 2011-05-27 | 2016-02-16 | Amira Pharmaceuticals, Inc. | Heterocyclic autotaxin inhibitors and uses thereof |
EP3046905A4 (en) | 2013-09-17 | 2017-03-22 | Pharmakea Inc. | Vinyl autotaxin inhibitor compounds |
EP3046909A4 (en) | 2013-09-17 | 2017-03-29 | Pharmakea, Inc. | Heterocyclic vinyl autotaxin inhibitor compounds |
EP3049405A4 (en) | 2013-09-26 | 2017-03-08 | Pharmakea Inc. | Autotaxin inhibitor compounds |
CN105793253B (zh) | 2013-11-22 | 2019-08-23 | 法玛克亚公司 | 自分泌运动因子抑制剂化合物 |
AU2016268250B2 (en) | 2015-05-27 | 2020-08-27 | Sabre Therapeutics Llc | Autotaxin inhibitors and uses thereof |
WO2018191146A1 (en) | 2017-04-10 | 2018-10-18 | Navitor Pharmaceuticals, Inc. | Heteroaryl rheb inhibitors and uses thereof |
Family Cites Families (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2003023A (en) * | 1930-10-16 | 1935-05-28 | Westinghouse Electric & Mfg Co | Mercury vapor or noble gas rectifier with arc control |
US3803143A (en) * | 1969-09-08 | 1974-04-09 | Eisai Co Ltd | 6-amino alkylene 6,7-dihydro-5h-dibenzo (b,g),(1,5)thiazocines |
US4018830A (en) * | 1969-09-22 | 1977-04-19 | Merck & Co., Inc. | Phenylthioaralkylamines |
US4055665A (en) * | 1974-11-25 | 1977-10-25 | Merck & Co., Inc. | Treating arrythmia with phenylthioaralkylamines |
US4056632A (en) * | 1975-07-21 | 1977-11-01 | Burroughs Wellcome Co. | 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use |
US4241071A (en) * | 1977-01-27 | 1980-12-23 | American Hoechst Corporation | Antidepressant (α-phenyl-2-tolyl)azacycloalkanes |
US4198417A (en) * | 1979-01-10 | 1980-04-15 | American Hoechst Corporation | Phenoxyphenylpiperidines |
DE3640475A1 (de) | 1986-11-27 | 1988-06-09 | Hoechst Sa Lab | Arzneimittel auf basis von derivaten des 3,4-diphenylpiperidins, die verwendung der derivate als arzneimittel sowie neue 3,4-diphenylpiperidinderivate und verfahren zu ihrer herstellung |
EP0396827A1 (en) | 1989-05-09 | 1990-11-14 | SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu | 2-Phenylthiobenzylamine dervivatives and acid addition salts thereof |
GB8912971D0 (en) * | 1989-06-06 | 1989-07-26 | Wellcome Found | Halogen substituted diphenylsulfides |
US6645969B1 (en) * | 1991-05-10 | 2003-11-11 | Aventis Pharmaceuticals Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
US5639752A (en) | 1991-11-25 | 1997-06-17 | Pfizer Inc | Indole derivatives |
GB9126311D0 (en) | 1991-12-11 | 1992-02-12 | Wellcome Found | Substituted diphenylsulfides |
GB9226532D0 (en) | 1992-12-21 | 1993-02-17 | Smithkline Beecham Plc | Compounds |
WO1995029897A1 (en) * | 1994-04-29 | 1995-11-09 | G.D. Searle & Co. | METHOD OF USING (H+/K+) ATPase INHIBITORS AS ANTIVIRAL AGENTS |
ATE294778T1 (de) | 1995-01-23 | 2005-05-15 | Daiichi Suntory Pharma Co Ltd | Verbesserung oder heilung von durch ischämischen krankheiten hervorgerufenen symtomen und dafür verwendbare phenylpiperidinverbingungen |
WO1997017352A1 (en) | 1995-11-06 | 1997-05-15 | Gist-Brocades B.V. | De-esterification process |
CZ293595A3 (cs) | 1995-11-09 | 1999-12-15 | Farmak A. S. | Deriváty N,N-dimethyl-2-(arylthio)benzylaminu, jejich soli, způsoby jejich přípravy a jejich použití v léčivých přípravcích |
US5912256A (en) * | 1996-06-20 | 1999-06-15 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
WO1998008817A1 (en) * | 1996-08-27 | 1998-03-05 | American Home Products Corporation | 4-aminoethoxy indoles as dopamin d2 agonists and as 5ht1a ligands |
US5906078A (en) * | 1996-10-09 | 1999-05-25 | Gallagher-Kaiser Corporation | Retaining strip for sheet covered enclosures |
GB9725953D0 (en) | 1997-12-08 | 1998-02-04 | Pfizer Ltd | Compounds useful in therapy |
DE19756036A1 (de) * | 1997-12-17 | 1999-06-24 | Merck Patent Gmbh | Amid- und Harnstoffderivate |
US6333146B1 (en) * | 1999-03-10 | 2001-12-25 | Fuji Photo Film Co., Ltd. | Methine compound and silver halide photographic material containing the same |
IL145528A0 (en) | 1999-04-02 | 2002-06-30 | Icos Corp | INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF |
CA2372481A1 (en) | 1999-04-30 | 2000-11-09 | The Trustees Of The University Of Pennsylvania | Spect imaging agents for serotonin transporters |
AU6621600A (en) | 1999-08-04 | 2001-03-05 | Millennium Pharmaceuticals, Inc. | Melanocortin-4 receptor binding compounds and methods of use thereof |
AU769430B2 (en) * | 1999-10-13 | 2004-01-29 | Pfizer Products Inc. | Biaryl ether derivatives useful as monoamine reuptake inhibitors |
US6410736B1 (en) * | 1999-11-29 | 2002-06-25 | Pfizer Inc. | Biaryl ether derivatives useful as monoamine reuptake inhibitors |
AU2152101A (en) | 1999-12-30 | 2001-07-16 | H. Lundbeck A/S | Substituted phenyl-piperazine derivatives, their preparation and use |
DK1464641T3 (da) | 1999-12-30 | 2008-08-18 | Lundbeck & Co As H | 4-phenylpiperazinyl-, -piperidinyl- og -tetrahydropyridylderivater som dopamin-D4-antagonister |
JP2003519223A (ja) | 1999-12-30 | 2003-06-17 | ハー・ルンドベック・アクチエゼルスカベット | フェニルピペラジニル誘導体 |
ATE481967T1 (de) * | 2000-02-29 | 2010-10-15 | Mediquest Therapeutics Inc | Melanozyten-tyrosinasehemmer als aufheller von topischen hauttypen |
WO2001087293A1 (fr) * | 2000-05-19 | 2001-11-22 | Takeda Chemical Industries, Ltd. | Inhibiteurs de la ?-secretase |
US6455738B1 (en) * | 2000-07-13 | 2002-09-24 | Rhodia Chimie | Process for the sulfonation of an aromatic compound |
US20030187023A1 (en) * | 2000-07-17 | 2003-10-02 | Keiji Kubo | Sulfone derivatives, process for their production and use thereof |
AU2001279955A1 (en) * | 2000-08-18 | 2002-03-04 | Sterix Limited | 2-substituted estradiol derivative for inhibiting superoxid dismutase |
KR20030059107A (ko) * | 2000-09-01 | 2003-07-07 | 에프엠씨 코포레이션 | 살충제로서의 이치환된 벤젠 |
WO2002020463A2 (en) * | 2000-09-05 | 2002-03-14 | Tularik Inc. | Fxr modulators |
EP1193268A1 (en) * | 2000-09-27 | 2002-04-03 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases |
EP1325046B1 (en) * | 2000-10-06 | 2007-06-27 | Biocompatibles UK Limited | Zwitterionic polymers |
WO2002030358A2 (en) * | 2000-10-11 | 2002-04-18 | Tularik Inc. | Modulation of ccr4 function |
BR0115296A (pt) | 2000-11-14 | 2003-09-02 | Merck Patent Ges Mit Beschonkt | Uso de inibidores de recaptação de sorotonina e agonistas de 5ht1a combinados |
US6436938B1 (en) * | 2001-01-22 | 2002-08-20 | Pfizer Inc. | Combination treatment for depression |
EP1363890A4 (en) | 2001-02-07 | 2009-06-10 | Ore Pharmaceuticals Inc | MELANOCORTIN-4-RECEPTOR BINDING COMPOUNDS AND METHOD FOR THEIR APPLICATION |
NZ529631A (en) | 2001-06-07 | 2006-08-31 | F | Indole derivatives with 5-hydroxytryptamine (5-HT) 5-HT6 receptor affinity in the treatment of disorders of the CNS |
EP1403255A4 (en) * | 2001-06-12 | 2005-04-06 | Sumitomo Pharma | INHIBITORS OF RHO KINASE |
UA81749C2 (uk) | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
US7064139B2 (en) * | 2001-10-29 | 2006-06-20 | Uniroyal Chemical Company, Inc. | Method for treating retroviral infections |
KR20050044417A (ko) * | 2001-11-14 | 2005-05-12 | 쉐링 코포레이션 | 카나비노이드 수용체 리간드 |
CN1606552A (zh) | 2001-12-21 | 2005-04-13 | H.隆德贝克有限公司 | 氨基茚满衍生物作为5-羟色胺和去甲肾上腺素摄取抑制剂 |
WO2003062290A1 (en) * | 2002-01-16 | 2003-07-31 | Biocompatibles Uk Limited | Polymer conjugates |
US20050261298A1 (en) * | 2002-01-18 | 2005-11-24 | David Solow-Cordero | Methods of treating conditions associated with an Edg-7 receptor |
ATE382154T1 (de) * | 2002-03-01 | 2008-01-15 | Fujifilm Corp | Farbphotographisches lichtempfindliches silberhalogenidmaterial |
WO2003074538A1 (fr) * | 2002-03-04 | 2003-09-12 | Japan Science And Technology Agency | Nouveaux phosphonamides, procede de production correspondant, et utilisation associee |
US7700200B2 (en) * | 2002-03-29 | 2010-04-20 | Massachusetts Institute Of Technology | Light emitting device including semiconductor nanocrystals |
DE10217006A1 (de) * | 2002-04-16 | 2003-11-06 | Merck Patent Gmbh | Substituierte Indole |
PE20040574A1 (es) * | 2002-06-19 | 2004-09-08 | Schering Corp | Agonistas de los receptores cannabinoides |
TW200401641A (en) * | 2002-07-18 | 2004-02-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands |
ES2311721T3 (es) * | 2002-09-17 | 2009-02-16 | F. Hoffmann-La Roche Ag | Indoles sustituidos en posicion 2,4 y su empleo como moduladores de 5-ht6. |
DK1587788T3 (da) * | 2002-09-17 | 2007-09-24 | Hoffmann La Roche | 2,7-substituerede indoler og anvendelsen deraf som 5-HT6-modulatorer |
EP1402888A1 (en) * | 2002-09-18 | 2004-03-31 | Jerini AG | The use of substituted carbocyclic compounds as rotamases inhibitors |
US20040266732A1 (en) * | 2002-09-20 | 2004-12-30 | Jorge Galvez | Therapeutic agents, methods, and treatments |
US20060189519A1 (en) * | 2002-09-26 | 2006-08-24 | Karl Volz | Anti-angiogenic fragments fo pigment epithelium-derived factor (pedf) |
US20040137389A1 (en) * | 2002-12-19 | 2004-07-15 | Kouta Fukui | Heat-developable light-sensitive material |
KR20050111314A (ko) * | 2002-12-20 | 2005-11-24 | 암젠 인코포레이션 | 천식 및 알레르기성 염증 조절제들 |
US7189501B2 (en) * | 2002-12-27 | 2007-03-13 | Fuji Photo Film Co., Ltd. | Silver halide color photographic photosensitive material |
DE10300098A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Ag | Kupfer-Carben-Komplexe und ihre Verwendung |
US7820753B2 (en) * | 2003-02-05 | 2010-10-26 | Biocompatibles Uk Limited | Block copolymers |
AR043633A1 (es) * | 2003-03-20 | 2005-08-03 | Schering Corp | Ligandos de receptores de canabinoides |
US7893096B2 (en) * | 2003-03-28 | 2011-02-22 | Novartis Vaccines And Diagnostics, Inc. | Use of small molecule compounds for immunopotentiation |
US7244763B2 (en) * | 2003-04-17 | 2007-07-17 | Warner Lambert Company Llc | Compounds that modulate PPAR activity and methods of preparation |
US20070060595A1 (en) * | 2003-10-10 | 2007-03-15 | Toshio Yoshizawa | Novel fused heterocyclic compound and use thereof |
US7229751B2 (en) * | 2003-11-20 | 2007-06-12 | Konica Minolta Medical & Graphic, Inc. | Silver salt photothermographic dry imaging material and image forming method using the same |
MXPA06007054A (es) * | 2003-12-19 | 2007-04-17 | Elixir Pharmaceuticals Inc | Metodos para tratar una enfermedad. |
ES2303960T3 (es) * | 2003-12-23 | 2008-09-01 | H. Lundbeck A/S | Derivados de 2-(1h-indolilsulfanil)-bencilamina como isrs. |
SE528250C2 (sv) | 2004-02-27 | 2006-10-03 | Calignum Technologies Ab | Komposition innefattande en initiator och ett förfarande för att behandla trä med kompositionen |
JP4569142B2 (ja) * | 2004-03-22 | 2010-10-27 | コニカミノルタホールディングス株式会社 | 表示素子 |
JP4448730B2 (ja) * | 2004-04-20 | 2010-04-14 | 富士フイルム株式会社 | 感光性組成物、該感光性組成物に用いられる化合物及び該感光性組成物を用いたパターン形成方法 |
WO2006006172A2 (en) | 2004-07-15 | 2006-01-19 | Ramot At Tel Aviv University Ltd. | Use of anti-amyloid agents for treating and typing pathogen infections |
US7732479B2 (en) | 2004-08-19 | 2010-06-08 | Tel Aviv University Future Technology Development L.P. | Compositions for treating amyloid associated diseases |
US7687229B2 (en) | 2004-08-24 | 2010-03-30 | Fujifilm Corporation | Silver halide color photographic light-sensitive material and image forming method |
CA2582658A1 (en) | 2004-10-08 | 2006-04-13 | Banyu Pharmaceutical Co., Ltd. | Method for producing thioether compound |
US20080132642A1 (en) | 2004-12-16 | 2008-06-05 | Serena Coiai | Process for Manufacturing a Thermoplastic Elastomeric Material |
-
2004
- 2004-12-21 ES ES04803045T patent/ES2303960T3/es active Active
- 2004-12-21 WO PCT/DK2004/000894 patent/WO2005061455A1/en active Application Filing
- 2004-12-21 PL PL04803045T patent/PL1701940T3/pl unknown
- 2004-12-21 BR BRPI0417858-0A patent/BRPI0417858B1/pt not_active IP Right Cessation
- 2004-12-21 RS RSP-2008/0315A patent/RS50589B/sr unknown
- 2004-12-21 EP EP04803045A patent/EP1701940B1/en active Active
- 2004-12-21 JP JP2006545921A patent/JP4090491B2/ja not_active Expired - Fee Related
- 2004-12-21 PT PT04803045T patent/PT1701940E/pt unknown
- 2004-12-21 AU AU2004303461A patent/AU2004303461B2/en not_active Ceased
- 2004-12-21 DK DK04803045T patent/DK1701940T3/da active
- 2004-12-21 MX MXPA06007172A patent/MXPA06007172A/es active IP Right Grant
- 2004-12-21 DE DE602004014190T patent/DE602004014190D1/de active Active
- 2004-12-21 SI SI200430784T patent/SI1701940T1/sl unknown
- 2004-12-21 AT AT04803045T patent/ATE396970T1/de active
-
2005
- 2005-12-21 US US11/314,702 patent/US7563908B2/en not_active Expired - Fee Related
-
2006
- 2006-06-04 IL IL176111A patent/IL176111A/en active IP Right Grant
-
2007
- 2007-06-05 JP JP2007148813A patent/JP4091648B2/ja active Active
- 2007-12-07 JP JP2007316676A patent/JP2008110984A/ja not_active Ceased
-
2008
- 2008-03-07 US US12/044,170 patent/US7652150B2/en not_active Expired - Fee Related
- 2008-03-17 US US12/049,403 patent/US7737171B2/en not_active Expired - Fee Related
- 2008-03-17 US US12/049,401 patent/US7737170B2/en not_active Expired - Fee Related
- 2008-06-19 HR HR20080274T patent/HRP20080274T3/xx unknown
- 2008-07-30 CY CY20081100801T patent/CY1108230T1/el unknown
-
2011
- 2011-05-20 CY CY20111100495T patent/CY1111733T1/el unknown
- 2011-05-27 HR HR20110400T patent/HRP20110400T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL176111A0 (en) | 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri | |
SE0303180D0 (sv) | Novel compounds | |
SE0302232D0 (sv) | Novel Compounds | |
NO20071642L (no) | N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger | |
SE0201635D0 (sv) | Novel compounds | |
CY1109998T1 (el) | Ενδυναμωτες υποδοχεων γλουταμινικου | |
SE0203713D0 (sv) | Novel compounds | |
EA200601391A1 (ru) | Производные хинолина для применения в качестве микобактериальных ингибиторов | |
EA200870127A1 (ru) | Полициклические производные аминокислот и способы их применения | |
TW200612905A (en) | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders | |
TW200611702A (en) | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders | |
EA200700400A1 (ru) | Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии | |
MY142988A (en) | Novel aminobenzophenone compounds | |
UY27872A1 (es) | Inhibidores de caspasa y usos de los mismos. | |
SE0502254L (sv) | Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission | |
NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
PL376324A1 (en) | Piperazinyl and diazapanyl benzamides and benzthioamides | |
MXPA05010000A (es) | Derivados de p-diaminobenceno substituidos. | |
SE0403171D0 (sv) | New compounds | |
EA200602180A1 (ru) | Производные 2-(1h-индолилсульфанил)ариламина для применения при лечении аффективных расстройств, боли, нгдв и стрессового недержания мочи | |
SE0401465D0 (sv) | New substituted piperdines as modulators of dopamine neurotransmission | |
BRPI0416030A (pt) | pirido-7-pirimidin-7-onas substituìdas com hidroxialquila | |
MXPA05009282A (es) | Derivados de anilina sustituidos. | |
BR0318521A (pt) | arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados | |
DK1819704T3 (da) | Pyrrolopyridin-2-carboxylsyre-amid-derivat anvendelig som inhibitor af glycogenphosphorylase |